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As part of an investigation i to the evolution of catabolic pathway enzymes a cloned gene encoding the Escherichia coli C 5-carboxymethyl-2- 
hydroxymuconate (CHM) isomerase, an enzyme of the homoprotocatechuate c abolic pathway, was used to produce large amounts of the protein. 
The isomerase was purified to homogeneity and some of its properties determined. The reaction occurred optimally at pH 7.6 and the specificity 
constant was 5.8 x l0 s M-l .s -1 with CHM and 6.0 x 10 z M-Ls -1 with 2-hydroxyhepta-2,4-diene-l,7-dioate, the substrate of a second isomerase 
in the pathway. The pure protein showed one type of subunit of Mr 14000 whilst the molecular mass of the native enzyme was 30000, suggesting 
that it was a dimer of identical subunits. The first 19 N-terminal amino acids were sequenced and the data used to confirm that the open reading 
frame of 378 bp, identified from the nucleotide sequence, ncoded the CHM isomerase. 
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1. INTRODUCTION 
How the enzymes that catalyse successive r actions in 
catabolic pathways have arisen is unclear. They may 
have evolved from a single ancestral gene, by a stepwise 
process of tandem gene duplication followed by muta- 
tion of the extra gene copy, and would thus be struc- 
turally related. Alternatively, they may have arisen by 
recruitment, from a variety of sources, of proteins with 
the appropriate catalytic properties and would 
therefore be structurally unrelated. It is also possible 
that, within a single pathway, both of these processes 
have occurred. 
The homoprotocatechuate (HPC) pathway is the 
bacterial route whereby 4-hydroxyphenylacetate, a pro- 
duct of phenylalanine and tyrosine breakdown and one 
of several compounds released uring the degradation 
of lignin, is catabolized. HPC is converted to succinic 
semialdehyde and pyruvate by a sequence of reactions 
initiated by meta-cleavage with dioxygen to give 
5-carboxymethyl-2-hydroxymuconate semialdehyde 
(CHMS) which in turn is oxidized in an NAD- 
dependent reaction to give 5-carboxymethyl-2- 
hydroxymuconate (CHM). The subsequent reactions of 
CHM involve, sequentially, isomerization, decarbox- 
ylation, isomerization, hydration and aldol cleavage 
(Fig. 1) [1-3], all of which depend on the presence of 
an enolizable oxo-group in the molecule [4]. So once a 
protein capable of isomerizing CHM was available 
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mutations of duplicated genes might have given rise 
fairly easily to altered proteins that could bring about 
the similar electronic shifts needed for decarboxylation, 
isomerization, hydration and aldol cleavage [4]. 
Analysis of the cloned HPC pathway genes and pro- 
teins therefore offers an opportunity o see whether en- 
zymes catalyzing chemically related reactions have 
arisen by modification of a single ancestral gene. This 
paper describes the nucleotide sequence, the derived 
amino acid sequence and some properties of CHM 
isomerase to serve as a basis for comparison when in- 
formation on the other pathway enzymes becomes 
available. 
2. MATERIALS AND METHODS 
2.1. Bacteria, plasmids and growth conditions 
Cells were grown aerobically at 37°C in Luria broth [5] containing 
100/zg. ml= 1 ampicillin. Liquid media were solidified as required by 
the incorporation of 1.6°70 (w/v) Bacto Agar (Difco Laboratories). 
The E. coli strain DHSa (Gibco-BRL) was used as host for the 
pUC18- and pUC19-based plasmids used in this study. The 3.0 kbp 
BamHI-Safl fragment of pJJS01 [3] was incorporated into pUCl8 
and pUC19 to give pDR1830 and pDR1930, respectively, pDRI930 
was used to prepare a nested set of deletions that included pDR9304 
and pDR9313-9317 (Fig. 3) using a Pharmacia exonuclease III dele- 
tion kit. pDR1830 was digested with BamHI and EcoRV to delete 
0.75 kbp of cloned DNA, the cohesive nds removed by digestion 
with SI nuclease and the blunt ends ligated to form pDR821 (Fig.3). 
2.2. Assay of  CHM isomerase 
The enzyme was assayed as described previously [2]. 
2.3. Purification o f  CHM isomerase 
CHM isomerase was purified from E. coli DHSc~(pDR9304). Cells 
grown overnight at 37°C in 800 ml medium were harvested by cen- 
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Fig. 1. Homoprotocatechuate (HPC) catabolic pathway in E. coli. The pathway intermediates are: 5-carboxymethyl-2-hydroxymuconate 
semialdehyde (CHMS); 5-carboxymethyl-2-hydroxymuconate (CHM); 5-carboxymethyl-2-oxo-hex-3-ene- 1,6-dioate (COHED); 
2-hydroxyhepta-2,4-diene-l,7-dioate (HHDD); 2-oxo-hept-3-ene-l,7-dioate (OHED); 2,4-dihydroxy-hept-2-ene-l,7-dioate (HHED) and succinic 
semialdehyde (SSA). CHM isomerase converts CHM to COHED and HHDD isomerase converts HHDD to OHED. 
trifugation at 10000 x g for 10 min at 4°C. The pellet was washed 
in 160 ml 20 mM Tris-HCl buffer, pH 7.5, and finally resuspended 
in 16 ml of the same buffer. Cells (4 ml portions) were ultrasonicated 
as described previously [6]. The crude extract was ultracentrifuged at 
180000 × g for 90 min at 4°C. The supernatant was treated with pro- 
tamine sulphate (40 mg. m1-1 in 20 mM Tris-HC1 buffer, pH 7.5) in 
the proportion 1mg protamine sulphate to 20 mg bacterial protein. 
The mixture was stirred gently at room temperature for 10 min then 
centrifuged at15000 x g for 15 rain at 4°C. The supernatant was ap- 
plied to an HR 10/10 Mono-Q anion exchange column and 
chromatographed using a Pharmacia fast protein liquid 
chromatography (FPLC) system. A 70 ml gradient of 0.0-0.5 M 
NaCI in 20 mM Tris-HCl buffer, pH 7.5, with a flow rate of 
4 ml. min-~ was used and the fractions with the highest specific ac- 
tivities, eluted at approx. 0.25 M NaCI, were pooled. The volume of 
the pooled fractions was reduced to 2 ml by ultrafiltration, 2 ml of 
1 M ammonium sulphate was added and the solution applied to an 
HR 5/5 Phenyl Superose column. A 10 ml gradient of 1.7-0.0 M 
ammonium sulphate in 0.1 M sodium phosphate buffer, pH 7.5, was 
applied at a flow rate of 0.5 ml.min-' .  The CHM isomerase was 
eluted at the end of the gradient. Fractions with the highest specific 
activities were pooled and the volume reduced to 2 ml by ultrafiltra- 
tion. Two Pharmacia HR 10/30 Superose 12 gel filtration columns 
connected in series were equilibrated with 50 mM sodium 
phosphate/0.15 M NaCI buffer, pH 7.5. The concentrated fraction 
was applied to this system and eluted at a flow rate of 0.4 ml. min -]. 
The CHM isomerase obtained was greater than 9907o pure as judged 
by SDS-PAGE. Details of the purification are given in Table I. Pro- 
tein in crude extracts was measured by the biuret method [7] and in 
purified extracts by the Folin method [8] using bovine serum albumin 
as standard. The concentration of the pure protein was measured 
spectrophotometrically using a value of 0.8 A28o per mg CHM 
isomerase calculated from the tryptophan and tyrosine content of the 
deduced amino acid sequence. 
2.4. Molecular mass estimation 
Native molecular masses were estimated by gel filtration as describ- 
ed under purification of CHM isomerase. The system was calibrated 
using IgG (160000); bovine serum albumin (66000); fl-lactoglobulin 
(35000) and cytochrome c (12400) as standards. Subunit molecular 
masses were estimated by SDS-polyacrylamide g l electrophoresis 
(PAGE) [9] using gradient gels of 7.5070 to 20°70 acrylamide. The pro- 
teins used to calibrate the gels were bovine serum albumin (66000); 
ovalbumin (45000); glyceraldehyde 3-phosphate dehydrogenase 
(36000); carbonic anhydrase (29000); trypsinogen (24000); trypsin 
inhibitor (20100) and bovine lactalbumin (14200). 
2.5. Amino acid sequencing 
The pure enzyme was run on a 7.507o-20070 SDS-polyacrylamide 
gradient gel and electroblotted onto a polyvinylidene difluoride 
(PVDF) membrane [10] using 50 mM glycine-50 mM Tris, pH 10, 
transfer buffer and stained with Coomassie blue R-250. The stained 
protein band was excised and loaded into an Applied Biosystems 
470A gas-phase sequencer without polybrene. 
2.6. DNA manipulations 
Small and large scale plasmid preparations were carried out by 
standard procedures [11]. Restriction endonucleases, T4 DNA ligase 
and exonuclease Ili deletion kit were used according to the manufac- 
turer's instructions. Isolation of DNA fragments from low melting 
point agarose gels was as described [12]. Transformations were car- 
ried out using the morpholinepropane sulphonic acid (MOPS)-RbC1 
method [13]. 
Table I 
A summary of the purification of E. coil C CHM isomerase 
Purification step Volume Total protein 
(ml) (mg) 
Total units Specific activity Recovery 
(umol.min -l) (umol.min -1 .mg (07o) 
protein-I) 
Purification 
(fold) 
Ultracentrifuged xtract 17.5 446.0 2292 5.1 100.0 0.0 
Protamine sulphate treated 
ultracentrifuged xtract 17.0 395.0 2924 7.4 127.5 1.5 
Pooled Mono-Q fractions 6.0 25.2 1656 65.9 72.2 12.9 
Pooled Phenyl Superose 
fractions 6.0 11.4 1445 127.6 63.0 25.0 
Pooled Superose 12 fractions 5.0 9.0 1335 148.3 58.2 29.1 
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2.1. Nucleotide sequencing 3.4. Nucleotide sequence of the CHh4 isomerase gene 
Nucleotide sequencing was carried out with T7 DNA polymerase 
according to Tabor and Richardson [14]. Plasmid DNA for sequenc- 
ing was prepared by the method of Kraft et al. [15]. 
2.8. Chemicals 
CHM was prepared as described [3]. Restriction endonucleases 
were from Gibco-BRL and Pharmacia, kits for DNA sequencing and 
for preparing deletions were exonuclease 111 were from Pharmacia. 
All other chemicals were of the highest grade commercially available. 
3. RESULTS AND DISCUSSION 
Unidirectional deletions were made from the Safl site 
in pDR1930 to produce a series of subclones. The en- 
zyme activity expressed by individual subclones was 
tested using crude extracts and CHM isomerase activity 
was found for subclones that retained greater than 
1.1 kbp of DNA from the BamHI site of the construct. 
The smallest deletion subclone to retain CHM 
isomerase activity was pDR93 17. Restriction maps and 
the nucleotide sequencing strategy employed are shown 
in Fig. 3. 
3.1. Purification of the enzyme 
Contrary to a previous report [3] the 3.0 kbp 
BamHI-SalI fragment of pJJ801 carries the gene for 
CHM isomerase (Roper and Cooper, unpublished 
results) as well as the HPC dioxygenase gene. When 
pDR1930 that carries this BamHI-SalI fragment was 
shortened by exonuclease III digestion one of the 
resulting plasmids (pDR9304) (Fig. 3), expressed much 
increased amounts of CHM isomerase and HPC diox- 
ygenase and was therefore used as a source of CHM 
isomerase. 
pwl1930 
pm9m 
pm9317 
3.2. Some properties of the purified enzyme 
The purified enzyme was stable for at least 4 weeks 
at 4°C. The effect of pH on the rate of reaction was 
measured in 0.1 M sodium phosphate buffer over the 
pH range of 6.6-8.6 and the optimum was at pH 7.6. 
At this pH the specificity constant (k&Km) [16] was 
5.8 x lo5 M-‘es-’ with CHM and 6.0 x lo2 M-‘.s-’ 
with 2-hydroxyhepta-2,4-diene-1,7-dioate, the sub- 
strate of the second isomerase in the pathway, in- 
dicating a strong preference for CHM. On SDS-PAGE 
the enzyme showed a single subunit of M, 14000. The 
h4, of the native enzyme estimated by gel filtration was 
30000 f 2000 suggesting that the enzyme is a dimer of 
identical subunits. 
pDR9316 
3.3. N-terminal amino acid sequence 
The first analysis indicated the presence of proline at 
position 1 so a second sample was subjected to an ex- 
tended trifluoroacetic acid cleavage step during the first 
cycle. An unambiguous sequence for the first 19 
residues was obtained with the exception of residue 7 
where no assignment was possible. A sample of the 
blotted protein was analysed by the procedure of 
Amons [17] and this resulted in the identification of 
cysteine at position 7. The first 19 residues of CHM 
isomerase are shown in Fig. 2. 
pm9311 
pm9313 
porfszl 
Pm0 
1 
Pro His Phe Ile Vat Glu Cys Ser Asp Ain 
19 
lie Atg Glu Glu Ala Asp Leu Pro Gly 
Fig. 2. N-terminal amino acid sequence of E. co/i C CHM isomerase. 
Fig. 3. Restriction map and sequencing strategy for the E. co/i C 
CHM isomerase gene. The 3.0 kbp BarnHI-San fragment (heavy 
line) cloned into pUCl9 to give pDR1930 is shown with major 
restriction sites. The restriction sites shown in the polylinker are not 
drawn to the same scale. Unidirectional deletion subclones were 
created from the .Sa/l end of the insert DNA by the exonuclease III 
digestion procedure. The coding strand encompassing CHM 
isomerase was sequenced using the deletion subclones pDR9317, 
pDR9316, pDR9314 and pDR9313 as shown. The arrows indicate the 
start, direction and extent of dideoxynucleotide sequencing carried 
out using the Ml3 reverse sequencing primer’. The complementary 
strand was sequenced from the polylinker EcoRl site of pDR821 
using the Ml3 reverse sequencing primer and continued (broad 
arrow) using a synthetic oligonucleotide based on the determined 
DNA sequence at positions 256-276 of the coding strand. The 378 bp 
region encoding the isomerase polypeptide is indicated by the hatched 
30x. Restriction sites are: E, EcoRI; Ss, Ml; K, KpnI; Sm, SmaI; B, 
PamHI; Ev, EcoRV; N, NdeI; S, San; P, PA; Sp, Sphl; H, HindIll. 
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A7 .1 
5' ACCGGTCAGGTTAACGCTGTTTCCCGCTTTCCGCGTAAG~ACGTTTT A G 3 
RBS met 1 
CCG CAC TTT ATC GTT GAA TGC AGT GAT AAC ATC CGC GAA GAA 
pro his phe ile val glu cys ser asp asn ile arg glu glu IS 
GCC GAC CTG CCG GGG TTG TTC GCC AAA GTG AAT CCG ACG CTG $7 
ala asp leu pro ~ly leu phe ala lys val ash pro thr leu 
GCA GCC ACG GGT ATT TTT CCG CTG GCG GGT ATT CGC AGC CGC I~ 
ala ala thr gly ile phe pro leu ala gly ile arg set arg 
GTG CAT TGG GTC GAT ACC TGG CAG ATG GCC GAC GGG CAG CAT 171 
val his trp val asp thr trp gln met ala asp gly gln his S7 
Ndel 
GAT TAT GCC TTC GTG CAT ATG ACG TTG AAA ATC GGC GCA GGT 213 
asp tyr ala phe val his met thr leu lys ile gly ala gly 71 
CGC AGC CTG GAA AGC CGC CAG CAG GCG GGT GAA ATG CTG TTT 2~ 
arg set leu glu ser arg gln gln ala gly glu met leu phe 85 
GAA CTG ATT AAA ACG CAC TTC GCC GCC CTG ATG GAG AGC CGC 2%7 
gly leu ile lys thr his phe ala ala leu met glu set arg 
CTG CTG GCG TTG TCG TTT GAG ATT GAA GAG CTG CAT CCG ACG 330 
leu leu ala leu set phe glu ile glu glu leu his pro thr 113 
CTG AAT TTT AAA CAA AAC AAC GTG CAC GCA TTG TTT AAG TGA 381 
leu asn phe lys gln asn ash val his ala leu phe lys END 126 
CGCGCAGATTGCCGGTGGCGCTTGCCGTTACCGGCCTACAAAACCCCAAACCGTA 436 
Eco RV 
CACCGTAGGCCGGATAAGGCGCACGCATCCGGCAATGCCACAGGATATC 3 ' 486 
Fig. 4. Nucleotide sequence and deduced amino acid sequence of the 
E. coil C CHM isomerase gene. The sequence is written in the 
5' ---*3' direction of the coding strand with the deduced amino acid 
sequence below. The EcoRV site downstream of the carhoxyl 
terminus and the internal Ndel site are indicated. The amino terminus 
of the gene was identified by matching the predicted sequence to the 
sequence obtained from the purified protein. The ribosome binding 
site (RBS) is shown. The numbers above the lines refer to the 
nucleotide positions and numbering begins with the ATG initiation 
codon. 
DNA sequencing was begun from the HindlII  site of 
pDR9317 towards the BamHI site utilizing the reverse 
primer site of pUC19. Because the deletion subclones 
had an average size difference of 100 bp and sequence 
for at least 300 residues was obtained from each con- 
struct there was very significant repetition of sequence 
measurement. The single-strand sequence was thus ob- 
tained with a high degree of accuracy. Sequence for the 
opposite strand was obtained by analysis of pDR821. 
The reverse primer site of pUC18 was used to obtain 
the sequence of the first 280 bases. A synthetic 
oligonucleotide corresponding to the sequence of bases 
256-276 was then constructed and used as a primer to 
obtain the sequence for a further 260 bases. Computer 
analysis of the nucleotide sequence revealed an open 
reading frame (ORF) of 378 bp with associated 
ribosome binding site [18] 186 bp upstream of the NdeI 
site. This ORF was confirmed as that encoding CHM 
isomerase since the predicted amino acid sequence for 
residues 2-20 corresponded exactly with the amino ter- 
minal amino acid sequence obtained from the pure pro- 
tein. The methionine at position 1 of the ORF is absent 
from the purified protein. The molecular mass 
calculated from the predicted amino acid sequence was 
14044 which agrees very well with that of the purified 
enzyme measured by SDS-PAGE. The nucleotide se- 
quence and predicted amino acid sequence for CHM 
isomerase are shown in Fig. 4. 
When various data bases were searched for other 
proteins with amino acid sequences similar to that of 
CHM isomerase no obvious matches were found. 
However, it will be possible to see whether CHM 
isomerase has any obvious sequence similarities to the 
other enzymes of the HPC catabolic pathway once the 
nucleotide and predicted amino acid sequences for 
those enzymes becomes available. In turn this might 
shed some light on how catabolic pathway enzymes 
have evolved. 
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